To date, BCRP has gained prominence as one of the three major ATP-binding cassette (ABC) membrane efflux transporters, alongside MDR1 and MRP, conferring drug resistance in cancer and inflammation chemotherapies [10], [11], [12]. The gene discussed is ABCG2; the disease is cancer.